GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (CHIX:ONTl) » Definitions » Beneish M-Score

Oxford Nanopore Technologies (CHIX:ONTL) Beneish M-Score : -2.18 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.18 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Oxford Nanopore Technologies's Beneish M-Score or its related term are showing as below:

CHIX:ONTl' s Beneish M-Score Range Over the Past 10 Years
Min: -3.63   Med: -1.93   Max: -1.11
Current: -2.18

During the past 6 years, the highest Beneish M-Score of Oxford Nanopore Technologies was -1.11. The lowest was -3.63. And the median was -1.93.


Oxford Nanopore Technologies Beneish M-Score Historical Data

The historical data trend for Oxford Nanopore Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Beneish M-Score Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -1.67 -3.63 -1.11 -2.18

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -1.11 - -2.18 -

Competitive Comparison of Oxford Nanopore Technologies's Beneish M-Score

For the Biotechnology subindustry, Oxford Nanopore Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Beneish M-Score falls into.



Oxford Nanopore Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Oxford Nanopore Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0548+0.528 * 1.169+0.404 * 2.1385+0.892 * 0.8543+0.115 * 0.999
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1869+4.679 * -0.022141-0.327 * 1.1034
=-2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was £42.3 Mil.
Revenue was £169.7 Mil.
Gross Profit was £90.5 Mil.
Total Current Assets was £447.2 Mil.
Total Assets was £777.1 Mil.
Property, Plant and Equipment(Net PPE) was £82.4 Mil.
Depreciation, Depletion and Amortization(DDA) was £41.6 Mil.
Selling, General, & Admin. Expense(SGA) was £155.2 Mil.
Total Current Liabilities was £89.2 Mil.
Long-Term Debt & Capital Lease Obligation was £37.3 Mil.
Net Income was £-154.5 Mil.
Gross Profit was £0.0 Mil.
Cash Flow from Operations was £-137.3 Mil.
Total Receivables was £47.0 Mil.
Revenue was £198.6 Mil.
Gross Profit was £123.8 Mil.
Total Current Assets was £638.0 Mil.
Total Assets was £823.9 Mil.
Property, Plant and Equipment(Net PPE) was £63.2 Mil.
Depreciation, Depletion and Amortization(DDA) was £31.9 Mil.
Selling, General, & Admin. Expense(SGA) was £153.1 Mil.
Total Current Liabilities was £91.5 Mil.
Long-Term Debt & Capital Lease Obligation was £30.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(42.326 / 169.668) / (46.97 / 198.603)
=0.249464 / 0.236502
=1.0548

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(123.81 / 198.603) / (90.481 / 169.668)
=0.623404 / 0.533283
=1.169

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (447.183 + 82.416) / 777.062) / (1 - (638 + 63.2) / 823.89)
=0.31846 / 0.148916
=2.1385

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=169.668 / 198.603
=0.8543

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(31.871 / (31.871 + 63.2)) / (41.627 / (41.627 + 82.416))
=0.335234 / 0.335585
=0.999

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(155.248 / 169.668) / (153.103 / 198.603)
=0.91501 / 0.7709
=1.1869

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((37.333 + 89.199) / 777.062) / ((30.042 + 91.539) / 823.89)
=0.162834 / 0.147569
=1.1034

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-154.507 - 0 - -137.302) / 777.062
=-0.022141

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Oxford Nanopore Technologies has a M-score of -2.18 suggests that the company is unlikely to be a manipulator.


Oxford Nanopore Technologies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

Oxford Nanopore Technologies Headlines

No Headlines